First human trial for experimental lupus drug begins – but no patients yet
NCT ID NCT06188507
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study is the first time the experimental drug GSK4347859 is given to humans. It aims to check the drug's safety and how it behaves in the body, not to treat any disease. About 65 healthy adults will receive either the drug or a placebo. The trial is currently on hold.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GSK Investigational Site
Cambridge, CB2 2GG, United Kingdom
-
GSK Investigational Site
Nottingham, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.